Visitor restrictions and mask requirements are still in place at all Scripps facilities. If you suspect you have COVID, please visit MyScripps first and answer the COVID-19 Symptom Checker questions. 

Your browser is out-of-date!

Internet Explorer 11 has been retired by Microsoft as of June 15, 2022. To get the best experience on this website, we recommend using a modern browser, such as Safari, Chrome or Edge.


Scripps Researcher Says New Trade Deal Could Help Medical Tech Cos.

New agreement would eliminate $1 trillion in tariffs on medical equipment and other high-tech goods


A new trade agreement hammered out between the United States and China could boost the competitive positions of San Diego area medical technology companies, Scripps Health Chief Academic Officer Eric Topol, MD, told the U-T San Diego.

“One local example is Illumina competing with (Beijing Genomics Institute) in China,” Dr. Topol said. “Taking down the tariffs could help Illumina compete in what is a ginormous market.”

Dr. Topol directs the Scripps Translational Science Institute, which conducts clinical trials around genomic medicine and wireless health technology. San Diego-based Illumina is the world’s leading seller of DNA sequencing machines.

The new trade agreement, which involves 54 countries, must be ratified through the World Trade Organization.

Read the U-T San Diego article: Tariff Deal Could Help Local Tech Companies

Media Contact

Keith Darce